REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 71 filers reported holding REVANCE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.63 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $277,000 | -75.0% | 9,000 | -72.3% | 0.01% | -75.0% |
| Q4 2015 | $1,110,000 | -14.9% | 32,511 | -25.8% | 0.02% | -9.1% |
| Q3 2015 | $1,305,000 | -45.8% | 43,844 | -41.7% | 0.02% | -38.9% |
| Q2 2015 | $2,407,000 | +25.8% | 75,261 | -18.5% | 0.04% | +24.1% |
| Q1 2015 | $1,914,000 | +28.5% | 92,339 | +4.9% | 0.03% | +26.1% |
| Q4 2014 | $1,490,000 | -6.8% | 87,984 | +6.4% | 0.02% | -4.2% |
| Q3 2014 | $1,598,000 | -74.6% | 82,655 | -55.3% | 0.02% | -75.3% |
| Q2 2014 | $6,282,000 | +324.7% | 184,766 | +293.5% | 0.10% | +288.0% |
| Q1 2014 | $1,479,000 | – | 46,954 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |